Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hermann Leistner Insider Profile
4 Followers
Hermann Leistner, Senior Officer at STRATEC Biomedical, holds ― shares in STRATEC Biomedical (Ticker: GB:0RAR).
Hermann Leistner has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Hermann Leistner does not currently own shares as a corporate insider.
A breakdown of Hermann Leistner's holdings
Insider Roles
Senior Officer
Roles that Hermann Leistner holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hermann Leistner
Hermann Leistner's Trading History
List of latest transactions for each holding click on a transaction to see Hermann Leistner's performance on stock
You May Also Like
Hermann Leistner insider profile FAQ
What is the percentage of profitable transactions made by Hermann Leistner?
The percentage of profitable transactions made by Hermann Leistner is ―.
What is the average return per transaction made by Hermann Leistner?
The average return per transaction made by Hermann Leistner is ―.
What stocks does Hermann Leistner hold?
Hermann Leistner holds: GB:0RAR stocks.
What was Hermann Leistner’s latest transaction?
Hermann Leistner latest transaction was an Uninformative Sell of ―.
What was Hermann Leistner's most profitable transaction?
Hermann Leistner’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hermann Leistner's role in STRATEC Biomedical?
Hermann Leistner's role in STRATEC Biomedical is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.